Home › Companies › SILENCE THERAPEUTICS PLC › 2024-2025
At SILENCE THERAPEUTICS PLC's shareholder meeting held June 26, 2025, in the 2024-2025 proxy season, 49 asset managers reported how they voted in their SEC Form N-PX filings, covering 285 separate fund positions. Their filings are grouped here into 17 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS… — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: SILENCE THERAPEUTICS PLC's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 27, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and SILENCE THERAPEUTICS PLC’s Form 8-K, filed June 27, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 26, 2025: 11 items on SILENCE THERAPEUTICS PLC’s Form 8-K, filed June 27, 2025: 11 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore SILENCE THERAPEUTICS PLC in the interactive database Compare manager voting policies
These tallies are SILENCE THERAPEUTICS PLC’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 27, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| To re-appoint as a director of the Company Tim McInerney. | 77,007,676 | 28,406 | 1,221,306 | -- | -- | 99.9% | Not verified | — |
| To re-appoint as a director of the Company Iain Ross. | 74,759,695 | 2,276,387 | 1,221,306 | -- | -- | 97% | Not verified | — |
| To re-appoint as a director of the Company Craig Tooman. | 78,228,674 | 28,408 | 306 | -- | -- | 99.9% | Not verified | — |
| To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | 70,771,045 | 3,076,664 | 4,409,679 | -- | -- | 96% | Not verified | — |
| To ratify the appointment of PricewaterhouseCoopers LLP as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2025. | 78,256,224 | 1,158 | 6 | -- | -- | 99.9% | Not verified | — |
| 2 Resolution 8 : To re-appoint PricewaterhouseCoopers LLP as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. | 78,253,224 | 1,158 | 3,006 | -- | -- | 99.9% | Not verified | — |
| To authorize the Audit & Risk Committee to determine the U.K. statutory auditors' remuneration for the year ending December 31, 2025. | 77,034,012 | 870 | 1,222,506 | -- | -- | 99.9% | Not verified | — |
| To receive and adopt the Company's U.K. statutory annual accounts and reports for the year ended December 31, 2024 (the "2024 U.K. | 78,218,008 | 665 | 38,715 | -- | -- | 99.9% | Not verified | — |
| To approve the directors' remuneration report for the year ended December 31, 2024, which is set forth as Annex A to the Proxy Statement and on pages 32 to 56 (inclusive) of the 2024 U.K. Annual Report. | 70,798,897 | 1,838,213 | 5,620,278 | -- | -- | 97% | Not verified | — |
| To approve the application of Article 159 of the Company's articles of association from the conclusion of this AGM to the conclusion of the next annual general meeting of the Company. | 77,027,104 | 1,625 | 1,228,659 | -- | -- | 99.9% | Not verified | — |
| Special Resolution 13 : That, with effect from the conclusion of the AGM, the draft articles of association produced to the AGM and, for the purpose of identification, initialed by the Chairman, be adopted as the articles of asso | 72,611,257 | 21,125 | 5,625,006 | -- | -- | 99.9% | Not verified | — |
Source: SILENCE THERAPEUTICS PLC, Form 8-K, filed with the SEC on June 27, 2025 — read the filing on EDGAR.
Each item below shows how the 49 asset managers that disclosed a SILENCE THERAPEUTICS PLC vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of SILENCE THERAPEUTICS PLC’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To re-appoint as a director Craig Tooman, who retires in accordance with the articles of association.
SILENCE THERAPEUTICS PLC’s own tally for this item (“Resolution 4 : To re-appoint as a director of the Company Craig Tooman.”): 78,228,674 for, 28,408 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 8 asset managers below reported 140,526 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 94,168 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 24,888 | 0 | 0 | 0 | For |
| Fidelity | 8,317 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 5,800 | 0 | 0 | 0 | For |
| State Street | 3,470 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,000 | 0 | 0 | 0 | For |
| ProShares | 1,879 | 0 | 0 | 0 | For |
| TIAA | 4 | 0 | 0 | 0 | For |
99.9% of fund votes cast · no official result
The 8 asset managers below reported 140,522 for, 4 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 94,168 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 24,888 | 0 | 0 | 0 | For |
| Fidelity | 8,317 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 5,800 | 0 | 0 | 0 | For |
| State Street | 3,470 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,000 | 0 | 0 | 0 | For |
| ProShares | 1,879 | 0 | 0 | 0 | For |
| TIAA | 0 | 4 | 0 | 0 | Against |
97% Majority: yes · of votes cast
Description as filed by funds: To re-appoint as a director Iain Ross, who retires in accordance with the articles of association.
SILENCE THERAPEUTICS PLC’s own tally for this item (“Resolution 3 : To re-appoint as a director of the Company Iain Ross.”): 74,759,695 for, 2,276,387 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 8 asset managers below reported 42,884 for, 97,642 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 94,168 | 0 | 0 | Against |
| ETFis Series Trust I | 24,888 | 0 | 0 | 0 | For |
| Fidelity | 8,317 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 5,800 | 0 | 0 | 0 | For |
| State Street | 0 | 3,470 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 2,000 | 0 | 0 | 0 | For |
| ProShares | 1,879 | 0 | 0 | 0 | For |
| TIAA | 0 | 4 | 0 | 0 | Against |
99.9% Majority: yes · of votes cast
Description as filed by funds: To re-appoint as a director Tim McInerney, who retires in accordance with the articles of association.
SILENCE THERAPEUTICS PLC’s own tally for this item (“Resolution 2 : To re-appoint as a director of the Company Tim McInerney.”): 77,007,676 for, 28,406 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 8 asset managers below reported 140,526 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 94,168 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 24,888 | 0 | 0 | 0 | For |
| Fidelity | 8,317 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 5,800 | 0 | 0 | 0 | For |
| State Street | 3,470 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,000 | 0 | 0 | 0 | For |
| ProShares | 1,879 | 0 | 0 | 0 | For |
| TIAA | 4 | 0 | 0 | 0 | For |
99.9% Majority: yes · of votes cast
Description as filed by funds: That, in accordance with Article 159.13(b) of the articles of association, Article 159 of the articles of association shall apply with effect from the conclusion of this AGM to the conclusion of the next annual general meeting of the Company.
SILENCE THERAPEUTICS PLC’s own tally for this item (“Resolution 12 : To approve the application of Article 159 of the Company's articles of association from the conclusion of this AGM to the conclusion of the next annual general meeting of the Company.”): 77,027,104 for, 1,625 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 8 asset managers below reported 140,524 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 94,168 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 24,888 | 0 | 0 | 0 | For |
| Fidelity | 8,317 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 5,800 | 0 | 0 | 0 | For |
| State Street | 3,468 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,000 | 0 | 0 | 0 | For |
| ProShares | 1,879 | 0 | 0 | 0 | For |
| TIAA | 4 | 0 | 0 | 0 | For |
99.9% Majority: yes · of votes cast
Description as filed by funds: That, with effect from the conclusion of the AGM, the draft articles of association produced to the AGM and, for the purpose of identification, initialed by the Chairman, be adopted as the articles of association of the Company in substitution for, and to the exclusion of, the Company's existing articles of association.
SILENCE THERAPEUTICS PLC’s own tally for this item (“Special Resolution Resolution 13 : That, with effect from the conclusion of the AGM, the draft articles of association produced to the AGM and, for the purpose of identification, initialed by the Chairman, be adopted as ”): 72,611,257 for, 21,125 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 8 asset managers below reported 140,524 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 94,168 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 24,888 | 0 | 0 | 0 | For |
| Fidelity | 8,317 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 5,800 | 0 | 0 | 0 | For |
| State Street | 3,468 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,000 | 0 | 0 | 0 | For |
| ProShares | 1,879 | 0 | 0 | 0 | For |
| TIAA | 4 | 0 | 0 | 0 | For |
99.9% Majority: yes · of votes cast
Description as filed by funds: To receive and adopt our U.K. statutory annual accounts and reports for the year ended December 31, 2024 (the "2024 U.K. Annual Report").
SILENCE THERAPEUTICS PLC’s own tally for this item (“Resolution 10 : To receive and adopt the Company's U.K. statutory annual accounts and reports for the year ended December 31, 2024 (the "2024 U.K.”): 78,218,008 for, 665 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 8 asset managers below reported 140,526 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 94,168 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 24,888 | 0 | 0 | 0 | For |
| Fidelity | 8,317 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 5,800 | 0 | 0 | 0 | For |
| State Street | 3,470 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,000 | 0 | 0 | 0 | For |
| ProShares | 1,879 | 0 | 0 | 0 | For |
| TIAA | 4 | 0 | 0 | 0 | For |
Combines 8 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.
SILENCE THERAPEUTICS PLC’s own tally for this item (“Resolution 5 : To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.”): 70,771,045 for, 3,076,664 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 16,657,765 for, 4 against, 7,078 1 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Lombard Odier Asset Management (Europe) Ltd | 3,277,854 | 0 | 0 | 0 | For |
| TCG Crossover Management, LLC | 3,033,560 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 2,442,757 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 2,164,777 | 0 | 0 | 0 | For |
| Lombard Odier Asset Management (USA) Corp | 1,268,117 | 0 | 0 | 0 | For |
| Vivo Capital, LLC | 1,105,454 | 0 | 0 | 0 | For |
| Nantahala Capital Management, LLC | 975,774 | 0 | 0 | 0 | For |
| Frazier Life Sciences Management, L.P. | 970,130 | 0 | 0 | 0 | For |
| 5AM Venture Management, LLC | 476,200 | 0 | 0 | 0 | For |
| Saturn V Capital Management LP | 249,799 | 0 | 0 | 0 | For |
| M28 Capital Management LP | 185,100 | 0 | 0 | 0 | For |
| Two Sigma | 156,992 | 0 | 0 | 0 | For |
| BlackRock | 111,025 | 0 | 0 | 0 | For |
| Woodline Partners LP | 62,459 | 0 | 0 | 0 | For |
| UBS | 50,955 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 24,888 | 0 | 0 | 0 | For |
| Citadel | 23,912 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 20,177 | 0 | 0 | 0 | For |
| Rhumbline | 7,078 | 0 | 0 | 0 | For |
| Fidelity | 8,317 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 8,317 | 0 | 0 | 0 | For |
| State Street | 6,941 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 5,800 | 0 | 0 | 0 | For |
| CIBC Private Wealth Group LLC | 4,331 | 0 | 0 | 0 | For |
| GAMMA Investing LLC | 3,112 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. All 49 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 0 | 0 | -- |
| ETFis Series Trust I | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| STEWARD FUNDS, INC. | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 8 managers: 140,524 1 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Lombard Odier Asset Management (Europe) Ltd | 0 | 0 | 0 | 0 | -- |
| TCG Crossover Management, LLC | 3,033,560 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 0 | 0 | 0 | 0 | -- |
| Lombard Odier Asset Management (USA) Corp | 0 | 0 | 0 | 0 | -- |
| Vivo Capital, LLC | 0 | 0 | 0 | 0 | -- |
| Frazier Life Sciences Management, L.P. | 0 | 0 | 0 | 0 | -- |
| 5AM Venture Management, LLC | 0 | 0 | 0 | 0 | -- |
| Saturn V Capital Management LP | 249,799 | 0 | 0 | 0 | For |
| M28 Capital Management LP | 0 | 0 | 0 | 0 | Not Voted |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| Woodline Partners LP | 0 | 0 | 0 | 0 | -- |
| UBS | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Rhumbline | 7,078 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| CIBC Private Wealth Group LLC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Citadel | 0 | 0 | 0 | 0 | -- |
| BANK OF MONTREAL /CAN/ | 0 | 0 | 0 | 0 | -- |
| Edward D. Jones & Co., L.P. | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| RBC Capital Markets, LLC | 0 | 0 | 0 | 0 | -- |
| Point72 | 0 | 0 | 0 | 0 | -- |
| Wescott Financial Advisory Group, LLC | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 31 managers: 3,290,437 for, 185,100 not voted, 9,884,078 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: TO APPROVE OUR DIRECTORS' REMUNERATION REPORT FOR THE YEAR ENDED DECEMBER 31, 2024, WHICH IS SET FORTH AS ANNEX A TO THE PROXY STATEMENT AND ON PAGES 32 TO 56 (INCLUSIVE) OF THE 2024 U.K. ANNUAL REPORT.
SILENCE THERAPEUTICS PLC’s own tally for this item (“Resolution 11 : To approve the directors' remuneration report for the year ended December 31, 2024, which is set forth as Annex A to the Proxy Statement and on pages 32 to 56 (inclusive) of the 2024 U.K. Annual Report.”): 70,798,897 for, 1,838,213 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 94,168 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 24,888 | 0 | 0 | 0 | For |
| Fidelity | 8,317 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 5,800 | 0 | 0 | 0 | For |
| State Street | 3,470 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,000 | 0 | 0 | 0 | For |
| ProShares | 1,879 | 0 | 0 | 0 | For |
| TIAA | 4 | 0 | 0 | 0 | For |
Fund voting reports, all 8 managers: 140,526 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Siren, L.L.C. | 2,442,757 | 0 | 0 | 0 | For |
| Saturn V Capital Management LP | 249,799 | 0 | 0 | 0 | For |
| BlackRock | 16,857 | 0 | 0 | 0 | For |
| Edward D. Jones & Co., L.P. | 2,500 | 0 | 0 | 0 | For |
| Wescott Financial Advisory Group, LLC | 400 | 0 | 0 | 0 | For |
| TRUIST FINANCIAL CORP | 262 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 214 | 0 | 0 | 0 | For |
| Savant Capital, LLC | 120 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 45 | 0 | 0 | 0 | For |
Institutional-manager reports, all 9 managers: 2,712,954 for.
Combines 2 wordings of this item as funds reported it.
0% of fund votes cast · no official result
Description as filed by funds: To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers - THREE YEARS
The 9 asset managers below reported 20,804 against, 2 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Citadel | 0 | 20,764 | 0 | 0 | Against |
| Morgan Stanley | 0 | 20 | 0 | 0 | Against |
| Lombard Odier Asset Management (Europe) Ltd | 0 | 5 | 0 | 0 | Against |
| State Street | 0 | 5 | 0 | 0 | Against |
| Legal & General Investment Management Ltd | 0 | 4 | 0 | 0 | Against |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0 | 0 | 2 | 0 | Abstain |
| KLP KAPITALFORVALTNING AS | 0 | 2 | 0 | 0 | Against |
| Lombard Odier Asset Management (USA) Corp | 0 | 2 | 0 | 0 | Against |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 0 | 2 | 0 | 0 | Against |
Combines 2 wordings of this item as funds reported it.
0% of fund votes cast · no official result
Description as filed by funds: To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers - TWO YEAR.
The 9 asset managers below reported 20,804 against, 2 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Citadel | 0 | 20,764 | 0 | 0 | Against |
| Morgan Stanley | 0 | 20 | 0 | 0 | Against |
| Lombard Odier Asset Management (Europe) Ltd | 0 | 5 | 0 | 0 | Against |
| State Street | 0 | 5 | 0 | 0 | Against |
| Legal & General Investment Management Ltd | 0 | 4 | 0 | 0 | Against |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0 | 0 | 2 | 0 | Abstain |
| KLP KAPITALFORVALTNING AS | 0 | 2 | 0 | 0 | Against |
| Lombard Odier Asset Management (USA) Corp | 0 | 2 | 0 | 0 | Against |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 0 | 2 | 0 | 0 | Against |
100% of fund votes cast · no official result
Description as filed by funds: To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers - One year
The 7 asset managers below reported 20,799 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Citadel | 20,764 | 0 | 0 | 0 | For |
| Morgan Stanley | 20 | 0 | 0 | 0 | For |
| State Street | 5 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 4 | 0 | 0 | 0 | For |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2 | 0 | 0 | 0 | For |
| KLP KAPITALFORVALTNING AS | 2 | 0 | 0 | 0 | For |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2 | 0 | 0 | 0 | For |
100% of fund votes cast · no official result
Description as filed by funds: To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers - 1 YEAR
The 2 asset managers below reported 7 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Lombard Odier Asset Management (Europe) Ltd | 5 | 0 | 0 | 0 | For |
| Lombard Odier Asset Management (USA) Corp | 2 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To authorize the Audit & Risk Committee to determine our U.K. statutory auditors' remuneration for the year ending December 31, 2025.
SILENCE THERAPEUTICS PLC’s own tally for this item (“Resolution 9 : To authorize the Audit & Risk Committee to determine the U.K. statutory auditors' remuneration for the year ending December 31, 2025.”): 77,034,012 for, 870 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 8 asset managers below reported 140,526 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 94,168 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 24,888 | 0 | 0 | 0 | For |
| Fidelity | 8,317 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 5,800 | 0 | 0 | 0 | For |
| State Street | 3,470 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,000 | 0 | 0 | 0 | For |
| ProShares | 1,879 | 0 | 0 | 0 | For |
| TIAA | 4 | 0 | 0 | 0 | For |
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending December 31, 2025
SILENCE THERAPEUTICS PLC’s own tally for this item (“Resolution 7 : To ratify the appointment of PricewaterhouseCoopers LLP as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2025.”): 78,256,224 for, 1,158 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 8 asset managers below reported 140,526 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 94,168 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 24,888 | 0 | 0 | 0 | For |
| Fidelity | 8,317 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 5,800 | 0 | 0 | 0 | For |
| State Street | 3,470 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,000 | 0 | 0 | 0 | For |
| ProShares | 1,879 | 0 | 0 | 0 | For |
| TIAA | 4 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of our next annual general meeting of shareholders.
SILENCE THERAPEUTICS PLC’s own tally for this item (“2 Resolution 8 : To re-appoint PricewaterhouseCoopers LLP as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders.”): 78,253,224 for, 1,158 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 8 asset managers below reported 140,526 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 94,168 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 24,888 | 0 | 0 | 0 | For |
| Fidelity | 8,317 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 5,800 | 0 | 0 | 0 | For |
| State Street | 3,470 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,000 | 0 | 0 | 0 | For |
| ProShares | 1,879 | 0 | 0 | 0 | For |
| TIAA | 4 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 141,690,850 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 0.07% |
| 2 | ETFis Series Trust I | 0.02% |
| 3 | Fidelity | <0.01% |
| 4 | STEWARD FUNDS, INC. | <0.01% |
| 5 | State Street | <0.01% |
| 6 | Blackstone Alternative Investment Funds | <0.01% |
| 7 | ProShares | <0.01% |
| 8 | TIAA | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Lombard Odier Asset Management (Europe) Ltd | 2.31% |
| 2 | TCG Crossover Management, LLC | 2.14% |
| 3 | Siren, L.L.C. | 1.72% |
| 4 | Redmile Group, LLC | 1.53% |
| 5 | Lombard Odier Asset Management (USA) Corp | 0.89% |
| 6 | Vivo Capital, LLC | 0.78% |
| 7 | Nantahala Capital Management, LLC | 0.69% |
| 8 | Frazier Life Sciences Management, L.P. | 0.68% |
| 9 | 5AM Venture Management, LLC | 0.34% |
| 10 | Saturn V Capital Management LP | 0.18% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Richard Ian Griffiths | 24.38% | 13D |
| Richard Griffiths | 20.88% | DEF14A |
| Robert Keith | 8.67% | DEF14A |
| TCG Crossover Fund I, L.P. | 6.42% | DEF14A |
| Invus Public Equities Advisors, LLC | 6.00% | DEF14A |
| Redmile Group, LLC | 4.69% | 13G |
| Lombard Odier Asset Management (USA) Corp | 4.19% | 13G |
| Craig Tooman | 2.22% | DEF14A |
| Morgan Stanley | 1.41% | 13F |
| Iain Ross | 0.87% | DEF14A |
Percentages above are of 141,690,850 shares outstanding, as reported by SILENCE THERAPEUTICS PLC on its Form 10-Q dated April 30, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SILENCE THERAPEUTICS PLC’s 10-Q dated April 30, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
SILENCE THERAPEUTICS PLC proxy season coverage: 2024-2025 (this page) · 2025-2026.
proxyvotesnow.com, “SILENCE THERAPEUTICS (SLN) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/silence-therapeutics-plc/2025 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.